DERMOXYL AQUA GEL 2.5% 2.5 %
BENZOYL PEROXIDE : 2.5 % · DIN 01950738 · ICN CANADA LTD.
Health Canada status: CANCELLED POST MARKET
What is DERMOXYL AQUA GEL 2.5%?
DERMOXYL AQUA GEL 2.5% 2.5 % contains BENZOYL PEROXIDE : 2.5 %. It is listed in the Health Canada Drug Product Database under DIN 01950738, held by ICN CANADA LTD., supplied as GEL for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Apr-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01950738 |
|---|---|
| Brand name | DERMOXYL AQUA GEL 2.5% |
| Generic / active ingredient | BENZOYL PEROXIDE : 2.5 % |
| Manufacturer | ICN CANADA LTD. |
| Strength | 2.5 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D10AE01 BENZOYL PEROXIDE |
| AHFS class | 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Apr-2005 |
| Original market date | 1992-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01950738 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1950738 |
| Brand name | DERMOXYL AQUA GEL 2.5% |
| Active ingredient / INN | BENZOYL PEROXIDE : 2.5 % |
| ATC code | D10AE01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D10 |
| AHFS class | 84:28.00 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | ICN CANADA LTD. |
Which pack is which?
| Strength on the label | 2.5 % |
|---|---|
| Dosage form | GEL |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code D10AE01 BENZOYL PEROXIDE. 34 of 208 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACNE CLEARING TREATMENT | 2.5 % | LOTION | RODAN & FIELDS BEAUTY, LLC | MARKETED | DIN 02463202 |
| ACNE FOAMING CLEANSER | 4 % | GEL | CERAVE CANADA | MARKETED | DIN 02508745 |
| ACNE FOAMING CLEANSER | 4 % | GEL | CRLS | MARKETED | DIN 02533715 |
| ACNE TREATMENT LOTION | 5 % | LOTION | VIVIER CANADA INCORPORATED | MARKETED | DIN 02336812 |
| ACTIVE ANTI-ACNE TREATMENT KIT | 2.5 % | LOTION ; KIT | FRUIT OF THE EARTH, INC | MARKETED | DIN 02444054 |
| BENZAC W WASH GEL 10% | 10 % | GEL | GALDERMA CANADA INC | MARKETED | DIN 01925199 |
| BENZAGEL 5 GEL | 5 % | GEL | COLUMBIA LABORATORIES CANADA INC | MARKETED | DIN 02162113 |
| BENZAGEL 5 WASH | 5 % | SOLUTION | COLUMBIA LABORATORIES CANADA INC | MARKETED | DIN 02162121 |
| BENZAGEL SPOT-ON ACNE GEL | 2.5 % | GEL | COLUMBIA LABORATORIES CANADA INC | MARKETED | DIN 02361949 |
| BENZOYL PEROXIDE ACNE TREATMENT 5% | 5 % | GEL | CRLS | MARKETED | DIN 02412012 |
Who else supplies BENZOYL PEROXIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BENZOYL PEROXIDE appears in 24 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.